Viking aims to enter the weight loss drug market.
StockStory.org on MSN
Viking (VIK): buy, sell, or hold post Q2 earnings?
Viking has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6%. The stock now trades ...
Viking Therapeutics (VKTX +1.56%) received a new buy rating from UBS on Oct. 14, with analyst Joon Lee assigning the stock a ...
Sharing the touchline brought a historic league title and a Champions League draw with Bayern Munich to Norway, proving two voices can be better than one ...
Viking Therapeutics (NASDAQ:VKTX) reported a wider third-quarter loss as it increased spending on late-stage obesity programs ...
AM Eastern Time on Tuesday, November 17, 2026, to discuss the company's third quarter 2026 financial results, which will be ...
Viking has announced its new 19-day "Grand Nile Journey" itinerary, with departures beginning in 2028. The new itinerary, ...
Operator: Welcome to the Viking Therapeutics Third Quarter 2026 Financial Results Conference Call. [Operator Instructions] As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results